Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.
about
Spotlight on histamine dihydrochloride in acute myeloid leukaemia.Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia.Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.Oxidative stress, redox regulation and diseases of cellular differentiation.Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.Current Knowledge and Perspectives on Histamine H1 and H2 Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands.Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosisFlow cytometric analysis with a fluorescently labeled formyl peptide receptor ligand as a new method to study the pharmacological profile of the histamine H2 receptor.Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia.
P2860
Q33394612-204E12EC-15D7-4BE6-87D7-9DE2760F8BDAQ33732606-2761C28E-2A39-4A61-B972-EFFA973A32DEQ35107809-F72E50FC-D245-42E2-9554-F72E89D3DC82Q35611511-C629E5E0-4BAA-4554-A584-2A44E781294EQ38193589-045B25A9-606A-42E3-92D8-EF6787FEB71AQ38208953-05E9E0F2-8BCE-4B13-BF45-BF6482BB0E89Q38953768-3AFA45A2-746B-4CD7-AA0D-FBB89B5B648CQ38973408-C615AA00-67C5-4D34-B34F-86B5EFD4E292Q39355305-79B199F2-ECD8-47E0-9153-DB52643A5A99Q40892572-E12D9F25-3C60-46C9-BDC7-6EAFB5B8027BQ41527981-6AD2F69D-6603-415D-B7E6-BF789867E932Q51696870-81B9967D-8E99-4589-94D2-17D0C0F5FA07
P2860
Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@en
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@nl
type
label
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@en
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@nl
prefLabel
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@en
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Immunotherapy with histamine d ...... pse in acute myeloid leukemia.
@en
P2093
Anna Martner
Johan Aurelius
Jonas Söderholm
Kristoffer Hellstrand
Mats Brune
P2860
P304
P356
10.1586/EHM.10.30
P577
2010-08-01T00:00:00Z